NCT06404944

Using of Implants With a Sloped Platform Edge

Name: Clinical Trial NCT06404944
Creator: I.M. Sechenov First Moscow State Medical University
Keywords: Bone Resorption, implantation, procedure, clinical trial, Russian Federation

The Use of Implants With a Sloped Platform Edge in Patients With Ridge Atrophy

I.M. Sechenov First Moscow State Medical University·ClinicalTrials.gov·procedureCompleted

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Bone Resorption
Drug/Device/Intervention: implantation
Study type: Interventional
Intervention type: procedure

Sponsor & location

Primary sponsor: I.M. Sechenov First Moscow State Medical University
Location: Moscow, Russian Federation

Timeline & enrollment

Phase: N/A
Start date: Jan 01, 2021
End date: Apr 01, 2024
Enrollment: 30 participants

Primary outcome

determination of the level of the marginal bone

Summary

An interventional prospective randomized clinical trial (RCT) was conducted in parallel groups. The sample size consisted of 30 patients who were randomly assigned to two groups based on the type of surgical intervention. The first group received implants with a sloped edge platform (Dentsply Sirona CIS, ASTRA TECH Implant System, registered in Russia on 21/12/2019, No. РЗН 2015/3214). The second group received implants with bone grafting. The assessment in the postoperative period included evaluating the condition of the soft tissues, bone resorption, number of analgesics, duration of the operation, edema, keratinized mucosa width, implant stability quotient, pain severity, and quality of life.

ICD-10 classifications

OsteolysisPathological resorption of teethBone donorPostsurgical malabsorption osteoporosisPostsurgical malabsorption osteoporosis with pathological fracture

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06404944
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06404944 through Pure Global AI's free database. This phase not specified trial is sponsored by I.M. Sechenov First Moscow State Medical University and is currently Completed. The study focuses on Bone Resorption. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.